<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2018-01-31" version="170">
<accession>P49588</accession>
<accession>A6NF14</accession>
<accession>B4DR45</accession>
<accession>Q53GV7</accession>
<accession>Q96FA0</accession>
<name>SYAC_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="13">Alanine--tRNA ligase, cytoplasmic</fullName>
<ecNumber evidence="13 20 21 22 23">6.1.1.7</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="13">Alanyl-tRNA synthetase</fullName>
<shortName evidence="13">AlaRS</shortName>
</alternativeName>
<alternativeName>
<fullName>Renal carcinoma antigen NY-REN-42</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="13">AARS</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Biochemistry" volume="34" first="10340" last="10349">
<title>Human alanyl-tRNA synthetase: conservation in evolution of catalytic core and microhelix recognition.</title>
<authorList>
<person name="Shiba K."/>
<person name="Ripmaster T.L."/>
<person name="Suzuki N."/>
<person name="Nichols R."/>
<person name="Plotz P."/>
<person name="Noda T."/>
<person name="Schimmel P."/>
</authorList>
<dbReference type="PubMed" id="7654687"/>
<dbReference type="DOI" id="10.1021/bi00033a004"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="432" first="988" last="994">
<title>The sequence and analysis of duplication-rich human chromosome 16.</title>
<authorList>
<person name="Martin J."/>
<person name="Han C."/>
<person name="Gordon L.A."/>
<person name="Terry A."/>
<person name="Prabhakar S."/>
<person name="She X."/>
<person name="Xie G."/>
<person name="Hellsten U."/>
<person name="Chan Y.M."/>
<person name="Altherr M."/>
<person name="Couronne O."/>
<person name="Aerts A."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Blumer H."/>
<person name="Branscomb E."/>
<person name="Brown N.C."/>
<person name="Bruno W.J."/>
<person name="Buckingham J.M."/>
<person name="Callen D.F."/>
<person name="Campbell C.S."/>
<person name="Campbell M.L."/>
<person name="Campbell E.W."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chasteen L.A."/>
<person name="Chertkov O."/>
<person name="Chi H.C."/>
<person name="Christensen M."/>
<person name="Clark L.M."/>
<person name="Cohn J.D."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Dickson M."/>
<person name="Dimitrijevic-Bussod M."/>
<person name="Escobar J."/>
<person name="Fawcett J.J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Goodwin L.A."/>
<person name="Grady D.L."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Hildebrand C.E."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Jewett P.B."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Krawczyk M.-C."/>
<person name="Leyba T."/>
<person name="Longmire J.L."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Ludeman T."/>
<person name="Manohar C.F."/>
<person name="Mark G.A."/>
<person name="McMurray K.L."/>
<person name="Meincke L.J."/>
<person name="Morgan J."/>
<person name="Moyzis R.K."/>
<person name="Mundt M.O."/>
<person name="Munk A.C."/>
<person name="Nandkeshwar R.D."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Parson-Quintana B."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Ricke D.O."/>
<person name="Robinson D.L."/>
<person name="Rodriguez A."/>
<person name="Salamov A."/>
<person name="Saunders E.H."/>
<person name="Scott D."/>
<person name="Shough T."/>
<person name="Stallings R.L."/>
<person name="Stalvey M."/>
<person name="Sutherland R.D."/>
<person name="Tapia R."/>
<person name="Tesmer J.G."/>
<person name="Thayer N."/>
<person name="Thompson L.S."/>
<person name="Tice H."/>
<person name="Torney D.C."/>
<person name="Tran-Gyamfi M."/>
<person name="Tsai M."/>
<person name="Ulanovsky L.E."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="White P.S."/>
<person name="Williams A.L."/>
<person name="Wills P.L."/>
<person name="Wu J.-R."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="DeJong P."/>
<person name="Bruce D."/>
<person name="Doggett N.A."/>
<person name="Deaven L."/>
<person name="Schmutz J."/>
<person name="Grimwood J."/>
<person name="Richardson P."/>
<person name="Rokhsar D.S."/>
<person name="Eichler E.E."/>
<person name="Gilna P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Pennacchio L.A."/>
</authorList>
<dbReference type="PubMed" id="15616553"/>
<dbReference type="DOI" id="10.1038/nature03187"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2007-07" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Glen H."/>
<person name="Brunton V.G."/>
<person name="Frame M.C."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 1-11; 304-320 AND 684-695</scope>
<scope>ACETYLATION AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Osteosarcoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="Int. J. Cancer" volume="83" first="456" last="464">
<title>Antigens recognized by autologous antibody in patients with renal-cell carcinoma.</title>
<authorList>
<person name="Scanlan M.J."/>
<person name="Gordan J.D."/>
<person name="Williamson B."/>
<person name="Stockert E."/>
<person name="Bander N.H."/>
<person name="Jongeneel C.V."/>
<person name="Gure A.O."/>
<person name="Jaeger D."/>
<person name="Jaeger E."/>
<person name="Knuth A."/>
<person name="Chen Y.-T."/>
<person name="Old L.J."/>
</authorList>
<dbReference type="PubMed" id="10508479"/>
<dbReference type="DOI" id="10.1002/(SICI)1097-0215(19991112)83:4&lt;456::AID-IJC4>3.0.CO;2-5"/>
</citation>
<scope>IDENTIFICATION AS A RENAL CANCER ANTIGEN</scope>
<source>
<tissue>Renal cell carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="336" first="496" last="506">
<title>Proteomic identification of proteins conjugated to ISG15 in mouse and human cells.</title>
<authorList>
<person name="Giannakopoulos N.V."/>
<person name="Luo J.K."/>
<person name="Papov V."/>
<person name="Zou W."/>
<person name="Lenschow D.J."/>
<person name="Jacobs B.S."/>
<person name="Borden E.C."/>
<person name="Li J."/>
<person name="Virgin H.W."/>
<person name="Zhang D.E."/>
</authorList>
<dbReference type="PubMed" id="16139798"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.08.132"/>
</citation>
<scope>ISGYLATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-555</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Science" volume="325" first="744" last="747">
<title>The C-Ala domain brings together editing and aminoacylation functions on one tRNA.</title>
<authorList>
<person name="Guo M."/>
<person name="Chong Y.E."/>
<person name="Beebe K."/>
<person name="Shapiro R."/>
<person name="Yang X.-L."/>
<person name="Schimmel P."/>
</authorList>
<dbReference type="PubMed" id="19661429"/>
<dbReference type="DOI" id="10.1126/science.1174343"/>
</citation>
<scope>DOMAIN EXCHANGE EXPERIMENTS</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-19 AND LYS-876</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-399</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.M111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-8 AND SER-555</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2015" name="Am. J. Hum. Genet." volume="96" first="675" last="681">
<title>Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect.</title>
<authorList>
<person name="Simons C."/>
<person name="Griffin L.B."/>
<person name="Helman G."/>
<person name="Golas G."/>
<person name="Pizzino A."/>
<person name="Bloom M."/>
<person name="Murphy J.L."/>
<person name="Crawford J."/>
<person name="Evans S.H."/>
<person name="Topper S."/>
<person name="Whitehead M.T."/>
<person name="Schreiber J.M."/>
<person name="Chapman K.A."/>
<person name="Tifft C."/>
<person name="Lu K.B."/>
<person name="Gamper H."/>
<person name="Shigematsu M."/>
<person name="Taft R.J."/>
<person name="Antonellis A."/>
<person name="Hou Y.M."/>
<person name="Vanderver A."/>
</authorList>
<dbReference type="PubMed" id="25817015"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2015.02.012"/>
</citation>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>INVOLVEMENT IN EIEE29</scope>
<scope>VARIANTS EIEE29 THR-81 AND GLY-751</scope>
<scope>CHARACTERIZATION OF VARIANTS EIEE29 THR-81 AND GLY-751</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22" evidence="1">
<citation type="submission" date="2014-12" db="PDB data bank">
<title>Crystal structure of wild type human AlaRS catalytic domain.</title>
<authorList>
<person name="Zhou H."/>
<person name="Yang X.L."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.28 ANGSTROMS) OF 1-455 IN COMPLEX WITH L-ALANINYL-ADENYLATE ANALOG</scope>
</reference>
<reference key="23" evidence="3">
<citation type="journal article" date="2016" name="J. Am. Chem. Soc." volume="138" first="12948" last="12955">
<title>Evolutionary Gain of Alanine Mischarging to Noncognate tRNAs with a G4:U69 Base Pair.</title>
<authorList>
<person name="Sun L."/>
<person name="Gomes A.C."/>
<person name="He W."/>
<person name="Zhou H."/>
<person name="Wang X."/>
<person name="Pan D.W."/>
<person name="Schimmel P."/>
<person name="Pan T."/>
<person name="Yang X.L."/>
</authorList>
<dbReference type="PubMed" id="27622773"/>
<dbReference type="DOI" id="10.1021/jacs.6b07121"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) OF 4-453 IN COMPLEX WITH L-ALANINYL-ADENYLATE ANALOG</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ALA-448</scope>
</reference>
<reference key="24" evidence="4 5">
<citation type="journal article" date="2016" name="Proc. Natl. Acad. Sci. U.S.A." volume="113" first="14300" last="14305">
<title>Two crystal structures reveal design for repurposing the C-Ala domain of human AlaRS.</title>
<authorList>
<person name="Sun L."/>
<person name="Song Y."/>
<person name="Blocquel D."/>
<person name="Yang X.L."/>
<person name="Schimmel P."/>
</authorList>
<dbReference type="PubMed" id="27911835"/>
<dbReference type="DOI" id="10.1073/pnas.1617316113"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 757-965</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Am. J. Hum. Genet." volume="86" first="77" last="82">
<title>A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease.</title>
<authorList>
<person name="Latour P."/>
<person name="Thauvin-Robinet C."/>
<person name="Baudelet-Mery C."/>
<person name="Soichot P."/>
<person name="Cusin V."/>
<person name="Faivre L."/>
<person name="Locatelli M.C."/>
<person name="Mayencon M."/>
<person name="Sarcey A."/>
<person name="Broussolle E."/>
<person name="Camu W."/>
<person name="David A."/>
<person name="Rousson R."/>
</authorList>
<dbReference type="PubMed" id="20045102"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2009.12.005"/>
</citation>
<scope>VARIANT CMT2N HIS-329</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E29393" last="E29393">
<title>The mutational spectrum in a cohort of Charcot-Marie-Tooth disease type 2 among the Han Chinese in Taiwan.</title>
<authorList>
<person name="Lin K.P."/>
<person name="Soong B.W."/>
<person name="Yang C.C."/>
<person name="Huang L.W."/>
<person name="Chang M.H."/>
<person name="Lee I.H."/>
<person name="Antonellis A."/>
<person name="Lee Y.C."/>
</authorList>
<dbReference type="PubMed" id="22206013"/>
<dbReference type="DOI" id="10.1371/journal.pone.0029393"/>
</citation>
<scope>VARIANT CMT2N TYR-71</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2012" name="Hum. Mutat." volume="33" first="244" last="253">
<title>A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).</title>
<authorList>
<person name="McLaughlin H.M."/>
<person name="Sakaguchi R."/>
<person name="Giblin W."/>
<person name="Wilson T.E."/>
<person name="Biesecker L."/>
<person name="Lupski J.R."/>
<person name="Talbot K."/>
<person name="Vance J.M."/>
<person name="Zuchner S."/>
<person name="Lee Y.C."/>
<person name="Kennerson M."/>
<person name="Hou Y.M."/>
<person name="Nicholson G."/>
<person name="Antonellis A."/>
</authorList>
<dbReference type="PubMed" id="22009580"/>
<dbReference type="DOI" id="10.1002/humu.21635"/>
</citation>
<scope>VARIANT CMT2N HIS-329</scope>
<scope>CHARACTERIZATION OF VARIANT CMT2N HIS-329</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2014" name="J. Neurol." volume="261" first="970" last="982">
<title>Whole-exome sequencing in patients with inherited neuropathies: outcome and challenges.</title>
<authorList>
<person name="Schabhuettl M."/>
<person name="Wieland T."/>
<person name="Senderek J."/>
<person name="Baets J."/>
<person name="Timmerman V."/>
<person name="De Jonghe P."/>
<person name="Reilly M.M."/>
<person name="Stieglbauer K."/>
<person name="Laich E."/>
<person name="Windhager R."/>
<person name="Erwa W."/>
<person name="Trajanoski S."/>
<person name="Strom T.M."/>
<person name="Auer-Grumbach M."/>
</authorList>
<dbReference type="PubMed" id="24627108"/>
<dbReference type="DOI" id="10.1007/s00415-014-7289-8"/>
</citation>
<scope>VARIANT MET-608</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="1348" last="1354">
<title>Deficient activity of alanyl-tRNA synthetase underlies an autosomal recessive syndrome of progressive microcephaly, hypomyelination, and epileptic encephalopathy.</title>
<authorList>
<person name="Nakayama T."/>
<person name="Wu J."/>
<person name="Galvin-Parton P."/>
<person name="Weiss J."/>
<person name="Andriola M.R."/>
<person name="Hill R.S."/>
<person name="Vaughan D.J."/>
<person name="El-Quessny M."/>
<person name="Barry B.J."/>
<person name="Partlow J.N."/>
<person name="Barkovich A.J."/>
<person name="Ling J."/>
<person name="Mochida G.H."/>
</authorList>
<dbReference type="PubMed" id="28493438"/>
<dbReference type="DOI" id="10.1002/humu.23250"/>
</citation>
<scope>VARIANT EIEE29 ASP-913</scope>
<scope>CHARACTERIZATION OF VARIANT EIEE29 ASP-913</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF CYS-723</scope>
</reference>
<comment type="function">
<text evidence="13 21 22 23">Catalyzes the attachment of alanine to tRNA(Ala) in a two-step reaction: alanine is first activated by ATP to form Ala-AMP and then transferred to the acceptor end of tRNA(Ala) (PubMed:28493438). Also edits incorrectly charged tRNA(Ala) via its editing domain (PubMed:28493438).</text>
</comment>
<comment type="catalytic activity">
<text evidence="13 20 21 22 23">ATP + L-alanine + tRNA(Ala) = AMP + diphosphate + L-alanyl-tRNA(Ala).</text>
</comment>
<comment type="cofactor">
<cofactor evidence="13">
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text evidence="13">Binds 1 zinc ion per subunit.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="20">3.1 uM for tRNA(Ala) (at 37 Celsius)</KM>
<text evidence="20">kcat is 0.4 sec(-1).</text>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="22">Monomer.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13 22">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P49588-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P49588-2</id>
<name>2</name>
<sequence type="described" ref="VSP_057201 VSP_057202"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="domain">
<text evidence="13">Consists of three domains; the N-terminal catalytic domain, the editing domain and the C-terminal C-Ala domain. The editing domain removes incorrectly charged amino acids, while the C-Ala domain, along with tRNA(Ala), serves as a bridge to cooperatively bring together the editing and aminoacylation centers thus stimulating deacylation of misacylated tRNAs.</text>
</comment>
<comment type="domain">
<text evidence="15">The C-terminal C-Ala domain (residues 756 to 968) is not required for catalytic activity and can bind DNA (in vitro) (PubMed:27911835). The C-terminal C-Ala domain (residues 756 to 968), along with tRNA(Ala), serves as a bridge to cooperatively bring together the editing and aminoacylation centers thus stimulating deacylation of misacylated tRNAs. The human domain can be used in vitro to replace the corresponding domain in E.coli (PubMed:19661429).</text>
</comment>
<comment type="PTM">
<text evidence="13 14">ISGylated.</text>
</comment>
<comment type="disease" evidence="16 17 18">
<disease id="DI-02678">
<name>Charcot-Marie-Tooth disease 2N</name>
<acronym>CMT2N</acronym>
<description>An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Nerve conduction velocities are normal or slightly reduced.</description>
<dbReference type="MIM" id="613287"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="20 23">
<disease id="DI-04412">
<name>Epileptic encephalopathy, early infantile, 29</name>
<acronym>EIEE29</acronym>
<description>A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE29 patients manifest severe infantile epileptic encephalopathy, clubfoot, absent deep tendon reflexes, extrapyramidal symptoms, and persistently deficient myelination.</description>
<dbReference type="MIM" id="616339"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="13">Belongs to the class-II aminoacyl-tRNA synthetase family.</text>
</comment>
<dbReference type="EC" id="6.1.1.7" evidence="13 20 21 22 23"/>
<dbReference type="EMBL" id="D32050">
<property type="protein sequence ID" value="BAA06808.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK299098">
<property type="protein sequence ID" value="BAG61157.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK222824">
<property type="protein sequence ID" value="BAD96544.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC012184">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471241">
<property type="protein sequence ID" value="EAW51839.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC011451">
<property type="protein sequence ID" value="AAH11451.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS32474.1">
<molecule id="P49588-1"/>
</dbReference>
<dbReference type="PIR" id="I60107">
<property type="entry name" value="I60107"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001596.2">
<molecule id="P49588-1"/>
<property type="nucleotide sequence ID" value="NM_001605.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.315137"/>
<dbReference type="PDB" id="4XEM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.28"/>
<property type="chains" value="A=1-455"/>
</dbReference>
<dbReference type="PDB" id="4XEO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.38"/>
<property type="chains" value="A/B=1-455"/>
</dbReference>
<dbReference type="PDB" id="5KNN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.68"/>
<property type="chains" value="A/B/C/D/E/F/G/H=4-453"/>
</dbReference>
<dbReference type="PDB" id="5T5S">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=757-965"/>
</dbReference>
<dbReference type="PDB" id="5T76">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=757-965"/>
</dbReference>
<dbReference type="PDBsum" id="4XEM"/>
<dbReference type="PDBsum" id="4XEO"/>
<dbReference type="PDBsum" id="5KNN"/>
<dbReference type="PDBsum" id="5T5S"/>
<dbReference type="PDBsum" id="5T76"/>
<dbReference type="ProteinModelPortal" id="P49588"/>
<dbReference type="SMR" id="P49588"/>
<dbReference type="BioGrid" id="106534">
<property type="interactions" value="54"/>
</dbReference>
<dbReference type="IntAct" id="P49588">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="MINT" id="MINT-1490092"/>
<dbReference type="STRING" id="9606.ENSP00000261772"/>
<dbReference type="BindingDB" id="P49588"/>
<dbReference type="ChEMBL" id="CHEMBL3574"/>
<dbReference type="DrugBank" id="DB00160">
<property type="generic name" value="L-Alanine"/>
</dbReference>
<dbReference type="iPTMnet" id="P49588"/>
<dbReference type="PhosphoSitePlus" id="P49588"/>
<dbReference type="SwissPalm" id="P49588"/>
<dbReference type="BioMuta" id="AARS"/>
<dbReference type="DMDM" id="115502460"/>
<dbReference type="EPD" id="P49588"/>
<dbReference type="MaxQB" id="P49588"/>
<dbReference type="PaxDb" id="P49588"/>
<dbReference type="PeptideAtlas" id="P49588"/>
<dbReference type="PRIDE" id="P49588"/>
<dbReference type="DNASU" id="16"/>
<dbReference type="Ensembl" id="ENST00000261772">
<molecule id="P49588-1"/>
<property type="protein sequence ID" value="ENSP00000261772"/>
<property type="gene ID" value="ENSG00000090861"/>
</dbReference>
<dbReference type="GeneID" id="16"/>
<dbReference type="KEGG" id="hsa:16"/>
<dbReference type="UCSC" id="uc002eyn.2">
<molecule id="P49588-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="16"/>
<dbReference type="DisGeNET" id="16"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000090861.15"/>
<dbReference type="GeneCards" id="AARS"/>
<dbReference type="GeneReviews" id="AARS"/>
<dbReference type="HGNC" id="HGNC:20">
<property type="gene designation" value="AARS"/>
</dbReference>
<dbReference type="HPA" id="CAB034261"/>
<dbReference type="HPA" id="HPA040870"/>
<dbReference type="HPA" id="HPA044223"/>
<dbReference type="MalaCards" id="AARS"/>
<dbReference type="MIM" id="601065">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613287">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616339">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P49588"/>
<dbReference type="OpenTargets" id="ENSG00000090861"/>
<dbReference type="Orphanet" id="228174">
<property type="disease" value="Autosomal dominant Charcot-Marie-Tooth disease type 2N"/>
</dbReference>
<dbReference type="PharmGKB" id="PA24367"/>
<dbReference type="eggNOG" id="KOG0188">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0013">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000016019"/>
<dbReference type="HOGENOM" id="HOG000156964"/>
<dbReference type="HOVERGEN" id="HBG017874"/>
<dbReference type="InParanoid" id="P49588"/>
<dbReference type="KO" id="K01872"/>
<dbReference type="OMA" id="FEMMAHH"/>
<dbReference type="OrthoDB" id="EOG091G00Z9"/>
<dbReference type="PhylomeDB" id="P49588"/>
<dbReference type="TreeFam" id="TF300737"/>
<dbReference type="Reactome" id="R-HSA-379716">
<property type="pathway name" value="Cytosolic tRNA aminoacylation"/>
</dbReference>
<dbReference type="ChiTaRS" id="AARS">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GenomeRNAi" id="16"/>
<dbReference type="PRO" id="PR:P49588"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000090861"/>
<dbReference type="CleanEx" id="HS_AARS"/>
<dbReference type="ExpressionAtlas" id="P49588">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P49588">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004813">
<property type="term" value="F:alanine-tRNA ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016597">
<property type="term" value="F:amino acid binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0002161">
<property type="term" value="F:aminoacyl-tRNA editing activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000049">
<property type="term" value="F:tRNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006419">
<property type="term" value="P:alanyl-tRNA aminoacylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021680">
<property type="term" value="P:cerebellar Purkinje cell layer development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050885">
<property type="term" value="P:neuromuscular process controlling balance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006418">
<property type="term" value="P:tRNA aminoacylation for protein translation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006400">
<property type="term" value="P:tRNA modification"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008033">
<property type="term" value="P:tRNA processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="HAMAP" id="MF_00036_B">
<property type="entry name" value="Ala_tRNA_synth_B"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR002318">
<property type="entry name" value="Ala-tRNA-lgiase_IIc"/>
</dbReference>
<dbReference type="InterPro" id="IPR018162">
<property type="entry name" value="Ala-tRNA-ligase_IIc_anticod-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR018165">
<property type="entry name" value="Ala-tRNA-synth_IIc_core"/>
</dbReference>
<dbReference type="InterPro" id="IPR018164">
<property type="entry name" value="Ala-tRNA-synth_IIc_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR023033">
<property type="entry name" value="Ala_tRNA_ligase_euk/bac"/>
</dbReference>
<dbReference type="InterPro" id="IPR003156">
<property type="entry name" value="DHHA1_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR018163">
<property type="entry name" value="Thr/Ala-tRNA-synth_IIc_edit"/>
</dbReference>
<dbReference type="InterPro" id="IPR009000">
<property type="entry name" value="Transl_B-barrel_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR012947">
<property type="entry name" value="tRNA_SAD"/>
</dbReference>
<dbReference type="Pfam" id="PF02272">
<property type="entry name" value="DHHA1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01411">
<property type="entry name" value="tRNA-synt_2c"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07973">
<property type="entry name" value="tRNA_SAD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00980">
<property type="entry name" value="TRNASYNTHALA"/>
</dbReference>
<dbReference type="SMART" id="SM00863">
<property type="entry name" value="tRNA_SAD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF101353">
<property type="entry name" value="SSF101353"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50447">
<property type="entry name" value="SSF50447"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55186">
<property type="entry name" value="SSF55186"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00344">
<property type="entry name" value="alaS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50860">
<property type="entry name" value="AA_TRNA_LIGASE_II_ALA"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0030">Aminoacyl-tRNA synthetase</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0144">Charcot-Marie-Tooth disease</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0436">Ligase</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0622">Neuropathy</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0648">Protein biosynthesis</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0820">tRNA-binding</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="chain" description="Alanine--tRNA ligase, cytoplasmic" id="PRO_0000075281">
<location>
<begin position="1"/>
<end position="968"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="1 2 3 21 24">
<location>
<begin position="214"/>
<end position="216"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="13">
<location>
<position position="605"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="13">
<location>
<position position="609"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="13">
<location>
<position position="723"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="13">
<location>
<position position="727"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="1 2 3 21 24">
<location>
<position position="77"/>
</location>
</feature>
<feature type="binding site" description="ATP; via amide nitrogen and carbonyl oxygen" evidence="1 2 3 21 24">
<location>
<position position="95"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="1 2 3 21 24">
<location>
<position position="176"/>
</location>
</feature>
<feature type="binding site" description="L-alanine" evidence="1 2 3 21 24">
<location>
<position position="216"/>
</location>
</feature>
<feature type="binding site" description="L-alanine" evidence="1 2 3 21 24">
<location>
<position position="239"/>
</location>
</feature>
<feature type="binding site" description="ATP; via amide nitrogen" evidence="1 2 3 21 24">
<location>
<position position="243"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="7 10 11 13 25">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="3"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="8"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="8">
<location>
<position position="19"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="399"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 12">
<location>
<position position="555"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="8">
<location>
<position position="876"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_057201" evidence="26">
<original>G</original>
<variation>GTYLYSFVR</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_057202" evidence="26">
<original>K</original>
<variation>KATQGPGSPPLGLISSL</variation>
<location>
<position position="869"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2N; dbSNP:rs387906792." id="VAR_067084" evidence="18">
<original>N</original>
<variation>Y</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE29; hypomorphic allele; results in only 2-fold reduction in aminoacylation efficiency; dbSNP:rs786205157." id="VAR_073719" evidence="20">
<original>K</original>
<variation>T</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11537667." id="VAR_028204">
<original>G</original>
<variation>D</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2N; severely reduces enzyme activity; dbSNP:rs267606621." id="VAR_063527" evidence="16 17">
<original>R</original>
<variation>H</variation>
<location>
<position position="329"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with distal hereditary motor neuropathy; unknown pathological significance." id="VAR_073293" evidence="19">
<original>T</original>
<variation>M</variation>
<location>
<position position="608"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE29; results in 10-fold reduction in aminoacylation efficiency; dbSNP:rs143370729." id="VAR_073720" evidence="20">
<original>R</original>
<variation>G</variation>
<location>
<position position="751"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE29; decreases protein abundance; decreases aminoacylation activity; no effect on the editing activity; dbSNP:rs369774476." id="VAR_079703" evidence="23">
<original>G</original>
<variation>D</variation>
<location>
<position position="913"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases misincorporation of Cys instead of Ala." evidence="21">
<original>A</original>
<variation>Q</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases editing activity." evidence="23">
<original>C</original>
<variation>A</variation>
<location>
<position position="723"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAA06808." ref="1" evidence="27">
<original>H</original>
<variation>Q</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG61157." ref="2" evidence="27">
<original>Y</original>
<variation>C</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG61157." ref="2" evidence="27">
<original>A</original>
<variation>T</variation>
<location>
<position position="763"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAD96544." ref="3" evidence="27">
<original>S</original>
<variation>T</variation>
<location>
<position position="867"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="7"/>
<end position="20"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="34"/>
<end position="36"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="45"/>
<end position="49"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="50"/>
<end position="53"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="62"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="68"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="78"/>
<end position="81"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="85"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="90"/>
<end position="93"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="96"/>
<end position="109"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="111"/>
<end position="123"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="130"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="133"/>
<end position="138"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="142"/>
<end position="144"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="150"/>
<end position="158"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="166"/>
<end position="169"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="171"/>
<end position="174"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="178"/>
<end position="195"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="201"/>
<end position="203"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="204"/>
<end position="207"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="211"/>
<end position="224"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="230"/>
<end position="243"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="244"/>
<end position="251"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="257"/>
<end position="259"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="261"/>
<end position="263"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="264"/>
<end position="274"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="284"/>
<end position="286"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="291"/>
<end position="310"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="319"/>
<end position="339"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="343"/>
<end position="345"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="346"/>
<end position="349"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="350"/>
<end position="357"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="358"/>
<end position="360"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="362"/>
<end position="365"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="368"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="386"/>
<end position="399"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="400"/>
<end position="402"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="408"/>
<end position="416"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="422"/>
<end position="431"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="438"/>
<end position="450"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="759"/>
<end position="782"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="789"/>
<end position="804"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="809"/>
<end position="851"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="856"/>
<end position="861"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="868"/>
<end position="881"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="886"/>
<end position="893"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="894"/>
<end position="897"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="898"/>
<end position="904"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="907"/>
<end position="912"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="916"/>
<end position="924"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="925"/>
<end position="928"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="929"/>
<end position="933"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="935"/>
<end position="943"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="945"/>
<end position="947"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="948"/>
<end position="960"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4XEM"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4XEO"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5KNN"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5T5S"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5T76"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="HAMAP-Rule" id="MF_03133"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16139798"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19661429"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20045102"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22009580"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22206013"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24627108"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25817015"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27622773"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27911835"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28493438"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source ref="22"/>
</evidence>
<evidence key="25" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000305"/>
<sequence length="968" mass="106810" checksum="8683F111CEE42506" modified="2006-10-03" version="2">
MDSTLTASEIRQRFIDFFKRNEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPS
HPMAKLSRAANTQKCIRAGGKHNDLDDVGKDVYHHTFFEMLGSWSFGDYFKELACKMALE
LLTQEFGIPIERLYVTYFGGDEAAGLEADLECKQIWQNLGLDDTKILPGNMKDNFWEMGD
TGPCGPCSEIHYDRIGGRDAAHLVNQDDPNVLEIWNLVFIQYNREADGILKPLPKKSIDT
GMGLERLVSVLQNKMSNYDTDLFVPYFEAIQKGTGARPYTGKVGAEDADGIDMAYRVLAD
HARTITVALADGGRPDNTGRGYVLRRILRRAVRYAHEKLNASRGFFATLVDVVVQSLGDA
FPELKKDPDMVKDIINEEEVQFLKTLSRGRRILDRKIQSLGDSKTIPGDTAWLLYDTYGF
PVDLTGLIAEEKGLVVDMDGFEEERKLAQLKSQGKGAGGEDLIMLDIYAIEELRARGLEV
TDDSPKYNYHLDSSGSYVFENTVATVMALRREKMFVEEVSTGQECGVVLDKTCFYAEQGG
QIYDEGYLVKVDDSSEDKTEFTVKNAQVRGGYVLHIGTIYGDLKVGDQVWLFIDEPRRRP
IMSNHTATHILNFALRSVLGEADQKGSLVAPDRLRFDFTAKGAMSTQQIKKAEEIANEMI
EAAKAVYTQDCPLAAAKAIQGLRAVFDETYPDPVRVVSIGVPVSELLDDPSGPAGSLTSV
EFCGGTHLRNSSHAGAFVIVTEEAIAKGIRRIVAVTGAEAQKALRKAESLKKCLSVMEAK
VKAQTAPNKDVQREIADLGEALATAVIPQWQKDELRETLKSLKKVMDDLDRASKADVQKR
VLEKTKQFIDSNPNQPLVILEMESGASAKALNEALKLFKMHSPQTSAMLFTVDNEAGKIT
CLCQVPQNAANRGLKASEWVQQVSGLMDGKGGGKDVSAQATGKNVGCLQEALQLATSFAQ
LRLGDVKN
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>